The life sciences industry continues to navigate significant legal and business developments across intellectual property, regulatory compliance, commercialization, and emerging technologies. Companies face increasing pressure to protect innovation while adapting to a rapidly evolving legal landscape.
Neal Gerber Eisenberg’s Life…
September 2026 brought several notable employment law developments, including new DOL guidance on meal breaks, volunteer work, and tip-sharing under the FLSA, as well as an NLRB decision restoring the General Motors standard for employee misconduct during protected activity. New…
Healthcare and benefits leaders face a growing challenge: controlling costs while supporting employee well-being, improving outcomes and navigating an increasingly complex regulatory environment. As organizations prepare for 2027, employer-sponsored healthcare plans continue to be shaped by rising specialty drug costs,…
Deals rarely fail for one reason alone. More often, they unravel when diligence uncovers risks that threaten timing, financing, valuation, ownership of key assets, or post-closing operations. This alert highlights several issues that can stop a transaction in its tracks,…
…
Intellectual Property partner Andrea Fuelleman was recently featured in a Bloomberg Law article, “Rebel’s Bankruptcy Only Stalls Van Leeuwen Judgment.”The case highlights the significant business risks that can arise when product packaging and branding create consumer confusion in the marketplace.…
